Aurexo Therapeutics’ Research & Development efforts are focused on advancing next-generation targeted therapeutics through its revolutionary engineered extracellular vesicle platform with inherent targeting capabilities. The company has established a broad and diverse pipeline encompassing multiple promising programs across a range of cancer indications. Grounded in deep scientific expertise and strengthened by licensed innovations developed in collaboration with strategic partners, Aurexo’s proprietary technology enables the safe, cost-effective, and scalable delivery of precision medicines. Ongoing research activities are dedicated to the identification, development, and validation of novel therapeutic candidates with the potential to address significant unmet medical needs and improve patient outcomes.